These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1493611)

  • 1. The regioselective binding of CHCl3 reactive intermediates to microsomal phospholipids.
    De Biasi A; Sbraccia M; Keizer J; Testai E; Vittozzi L
    Chem Biol Interact; 1992 Dec; 85(2-3):229-42. PubMed ID: 1493611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
    Gemma S; Sbraccia M; Testai E; Vittozzi L
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):45-7. PubMed ID: 7698083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivation of chloroform in hepatic microsomes from rodent strains susceptible or resistant to CHCl3 carcinogenicity.
    Testai E; Gemma S; Vittozzi L
    Toxicol Appl Pharmacol; 1992 Jun; 114(2):197-203. PubMed ID: 1609411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of electrophilic and radicalic intermediates to phospholipid adducts formed by halomethanes in vivo.
    De Curtis V; Gemma S; Sbraccia M; Testai E; Vittozzi L
    J Biochem Toxicol; 1994 Dec; 9(6):305-10. PubMed ID: 7891366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro quantitative determination of phospholipid adducts of chloroform intermediates in hepatic and renal microsomes from different rodent strains.
    Gemma S; Ade P; Sbraccia M; Testai E; Vittozzi L
    Environ Toxicol Pharmacol; 1996 Oct; 2(2-3):233-42. PubMed ID: 21781732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethanol on CHCl3 metabolism in hepatic microsomes from Osborne-Mendel rats.
    Testai E; Gemma S; Gervasi P; Menicagli S; Vittozzi L
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):25-30. PubMed ID: 7698079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
    Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
    J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary characterization of phospholipid adducts formed by [14C]-CHCl3 reactive intermediates in hepatocyte suspensions.
    Guastadisegni C; Balduzzi M; Vitozzi L
    J Biochem Toxicol; 1996; 11(1):21-5. PubMed ID: 8806048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice.
    Ade P; Guastadisegni C; Testai E; Vittozzi L
    J Biochem Toxicol; 1994 Dec; 9(6):289-95. PubMed ID: 7891364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro investigation of the reductive metabolism of chloroform.
    Testai E; Di Marzio S; di Domenico A; Piccardi A; Vittozzi L
    Arch Toxicol; 1995; 70(2):83-8. PubMed ID: 8773179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-hexanone potentiation of [14C]chloroform hepatotoxicity: covalent interaction of a reactive intermediate with rat liver phospholipid.
    Cowlen MS; Hewitt WR; Schroeder F
    Toxicol Appl Pharmacol; 1984 May; 73(3):478-91. PubMed ID: 6719463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice.
    Smith JH; Hook JB
    Toxicol Appl Pharmacol; 1984 May; 73(3):511-24. PubMed ID: 6719466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo.
    Uehleke H; Werner T
    Arch Toxicol; 1975 Dec; 34(4):289-308. PubMed ID: 3152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative characterization of CHCl(3) metabolism and toxicokinetics in rodent strains differently susceptible to chloroform-induced carcinogenicity.
    Vittozzi L; Gemma S; Sbraccia M; Testai E
    Environ Toxicol Pharmacol; 2000 Jan; 8(2):103-110. PubMed ID: 10867369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique.
    Tomasi A; Albano E; Biasi F; Slater TF; Vannini V; Dianzani MU
    Chem Biol Interact; 1985 Nov; 55(3):303-16. PubMed ID: 3000632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of methyl-N-butyl ketone and phenobarbital on rat liver cytochromes P-450 and the metabolism of chloroform to phosgene.
    Branchflower RV; Schulick RD; George JW; Pohl LR
    Toxicol Appl Pharmacol; 1983 Dec; 71(3):414-21. PubMed ID: 6658790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
    Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism.
    Testai E; Vittozzi L
    Chem Biol Interact; 1986 Sep; 59(2):157-71. PubMed ID: 3769050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a phospholipid adduct formed in Sprague Dawley rats by chloroform metabolism: NMR studies.
    Guastadisegni C; Guidoni L; Balduzzi M; Viti V; Di Consiglio E; Vittozzi L
    J Biochem Mol Toxicol; 1998; 12(2):93-102. PubMed ID: 9443066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species and strain differences in the hepatic cytochrome P450-mediated biotransformation of 1,4-dichlorobenzene.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):1-9. PubMed ID: 9221818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.